22 related articles for article (PubMed ID: 3839542)
1. Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.
Flodgren P; Sjögren HO
Cancer Immunol Immunother; 1985; 19(1):28-34. PubMed ID: 3844972
[TBL] [Abstract][Full Text] [Related]
2. The effect of cimetidine on PBL from healthy donors and melanoma patients: augmentation of T cell responses to TCGF mitogens and alloantigens and of TCGF production.
Eisenthal A; Monselise J; Zinger R; Adler A
Cancer Immunol Immunother; 1986; 21(2):141-7. PubMed ID: 2936446
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract.
Lotzová E; Savary CA; Freedman RS; Bowen JM
Cancer Immunol Immunother; 1984; 17(2):124-9. PubMed ID: 6205745
[TBL] [Abstract][Full Text] [Related]
4. Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells.
Allavena P; Lo Presti P; Di Bello M; Lucchini V; Lissoni A; Zanetta G; Mangioni C; Mantovani A
Cancer Immunol Immunother; 1988; 27(1):69-76. PubMed ID: 2969284
[TBL] [Abstract][Full Text] [Related]
5. Perioperative cimetidine application modulates natural killer cells in patients with colorectal cancer: a randomized clinical study.
Bai D; Yang G; Yuan H; Li Y; Wang K; Shao H
J Tongji Med Univ; 1999; 19(4):300-3. PubMed ID: 12938523
[TBL] [Abstract][Full Text] [Related]
6. Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.
Bücklein V; Adunka T; Mendler AN; Issels R; Subklewe M; Schmollinger JC; Noessner E
Oncoimmunology; 2016 Jul; 5(7):e1178421. PubMed ID: 27622032
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral lymphocyte examination--evaluation and application of the tests in the diagnosis of liver disease].
Kado Y; Okita K; Takemoto T
Rinsho Byori; 1986 Jun; 34 Spec No 67():216-22. PubMed ID: 3534357
[No Abstract] [Full Text] [Related]
8. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
9. Augmented natural killer activity in ovarian cancer patients treated with cimetidine.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1037-43. PubMed ID: 3780810
[TBL] [Abstract][Full Text] [Related]
10. [Effects of cimetidine and PSK on interleukin-2 production by PBL in patients with advanced ovarian carcinoma during the course of chemotherapy].
Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Miyauchi M; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1987-92. PubMed ID: 3501452
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
12. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
13. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]